SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " sano " 67 found 🔀 AI-powered Shuffle
What causes sleep paralysis; health indicators of Alzheimer's diagnosis; sober October; plus other stories with Vanderbilt Health sources
(iStock) Food and Wine interviewed Peter Martin, MD, Professor of Psychiatry and Behavioral Sciences, for a story about sober October. William Schaffner, MD, Professor of Preventive Medicine, was quoted in CNN International’s Connect the World with Becky Anderson and NewsNation Morning in America for stories about the reported plague situation in Russia, after a laboratory worker at an institute in Siberia dedicated to studying the plague and other infectious diseases died of a mysterious illness. Prevention interviewed James McGuirk, MD, Assistant Professor, Division of Sleep Medicine, for a story about what causes sleep paralysis. Modern Healthcare interviewed Daniel Fabbri, PhD, Associate Professor of Biomedical Informatics and Computer Science, for a story about how health systems are managing AI token costs. WNKY interviewed Ziv Beckerman, MD, Associate Chief of Pediatric Cardiac Surgery, Surgical Director of Pediatric Heart Transplantation in the Golisano Pediatric Heart Institute at Monroe Carell Jr. Children’s Hospital at Vanderbilt about rapid recovery with extended ultra oxygenated preservation (REUP) that is a new form of preservation for heart organs. Ray Romano, PhD, MPH, MSN, Nurse Practitioner, Vanderbilt Memory & Alzheimer’s Center, was quoted Prevention about research that found other health issues may be an early indicator of Alzheimer’s.
Be a Friend Campaign Supports Child Cancer Program at Lee Health Golisano Children’s - Florida Hospital News and Healthcare Report
Oct. 14, 2026 – Throughout Childhood Cancer Awareness Month, Southwest Florida community united to support local children facing cancer and blood disorders through the Be a Friend campaign benefiting Barbara’s […]
Panda Express Pledges $391K+ to Support Lee Health Golisano Children's Through Children's Miracle Network - Florida Hospital News and Healthcare Report
Oct. 13, 2026)– Panda Express has reaffirmed its commitment to Southwest Florida children and families with a pledge to raise more than $391,000 for Lee Health Golisano Children’s through Children’s […]
Fatal Fury: City of the Wolves DLC characters Manjiro Sano and Ken Ryuguji trailers, screenshots
SNK has released a new set of trailers and screenshots for Fatal Fury: City of the Wolves downloadable content characters Manjiro “Mikey” Sano and Ken “Draken” Ryuguji from …
Open science is compatible with research security, says Canada’s chief science advisor
Open science is “not incompatible” with research security and science leaders and policymakers should “demystify” the false dichotomy between the two, according to Mona Nemer, Canada’s chief science advisor. More than a decade ago, EU policymakers were promoting open science, open innovation and open collaboration across the world. It was a political movement that aimed to make scientific research, data, software, publications and methodologies transparent, accessible and reusable for everyone.But that rhetoric has changed over the past few years. After Russia invaded Ukraine in 2022 and Donald Trump came back to power in 2025, international partnerships have become more pragmatic. Countries are trying to implement protectionist policies and governments are increasingly worried about technology espionage. According to Nemer, science can remain open if the sector can come up with improved security protocols that would protect research data from undue manipulation by foreign actors. “If anybody can fiddle with the with the data, then [open science] is actually quite dangerous and quite useless,” she told Science|Business. Universities and research institutions are increasingly vulnerable to attempted espionage and other types of foreign interference. In September, the UK’s domestic counter-intelligence service MI5 issued a security warning against collaborations with the China General Technology Research Institute. And earlier this year, Germany’s Helmholtz Center for Information Security was criticised by federal research minister Dorothee Bär, who told a parliamentary hearing that “existing rules and systems” at the institute “were not suitable” for preventing leaks to China. According to Nemer, universities and research institutions should perhaps follow the example of the private sector, as companies have been able to safeguard their research while still publishing results. “I think that there is a level of research security hygiene that researchers and institutions need to just adopt,” she said. “You don't have to tell Sanofi or IBM how to safeguard their research, which they end up publishing anyway.”While certain areas of research will not be open for collaboration with certain partners, in other areas cooperation is necessary even with researchers based in adversarial countries. “I stress this because politics change,” she said. “Science and politics don't make for good fellows, and whether we like it or not, politics will influence certain things.”Researchers will play an important role in “protecting the integrity of science,” said Nemer. “I think that it's time that there's a commitment to a certain scientific compact, so that citizens don't think that science is actually an open door for espionage and for anti-nationalism.”New partnershipsNemer spoke with Science|Business on the margins of the Hamburg Science Summit on September 17, the day when Canadian Prime Minister Mark Carney called for increased cooperation with the EU, including in science and technology. Canada is looking to strengthen ties with partners in other corners of the world, after the Trump administration threatened to put tariffs on Canadian goods and services and even openly suggested Canada could become the 51st state. In parallel, the US government has indicated it wants to retreat from international science projects, including US collaboration with Europe’s CERN particle accelerator and other big science labs.Related articlesThe stats we need to better understand R&DCanada looks to deepen research and education links with the EUCan researchers trust that AI models won’t leak their ideas?Nemer said the US is still a science “powerhouse,” but Canada and Europe will have to work closely together on global challenges. “It’s important for both [sides], but I think it's also important for the rest of the world, because the cut in funding for development, in health, in regions like Africa and other places, have dramatic effects.” The Trump administration is also planning a review of the Nelson memo, a Biden-era document that mandated that results of federally funded research would be openly available. With that idea being called into question, Nemer said it could be “very disruptive” to scientific collaborations and could jeopardise research on climate change, the Arctic and global health. “When your collaborator suddenly tells you I'm not going to share the data with you as a researcher, if this happens, I think it's very worrisome,” she said. “I'm certainly hoping that a lot of the Canadian institutions, funders, researchers, have started looking at joining forces on databases and using more European research infrastructures,” Nemer added.
Forbes names science center as top 250 healthcare employer in new ranking
Forbes ranked the UT Health Science Center at San Antonio in the top 250 healthcare employers for 2026 alongside two other hospital systems in San Antonio. University Health was ranked at 128, Baptist Health System at 199 and the UT Texas Health Science Center at San Antonio at 240. This list determines which hospital systems...
Marlins’ Javier Sanoja Poised for Breakout 2027 Season
After a career-best 2026 season, the Marlins are banking on Javier Sanoja to become an everyday contributor in 2027 and beyond.
New exhibit chronicles Tom Golisano’s business and philanthropic legacy
The Golisano Institute in Buffalo unveiled a permanent exhibit honoring founder Tom Golisano’s business, philanthropy and civic leadership legacy.
Bryson’s story: Penn State Health delivers coordinated care for Lancaster family
After newborn Bryson Geiss was transferred to Penn State Health Golisano Children’s Hospital for specialized NICU care, he recovered quickly and went home with his family just two days later.
Wave Life Sciences Appoints Monika Vnuk as Chief Business Officer
Wave Life Sciences appoints Monika Vnuk, MD, as Chief Business Officer to lead business and corporate development efforts.Quiver AI SummaryWave Life Sciences Ltd. announced the appointment of Dr. Monika Vnuk as Chief Business Officer, bringing extensive experience from her previous roles at Sanofi, Blackstone, and Pfizer. In her new role, Dr. Vnuk will oversee business and corporate development, as well as alliance management, aimed at advancing
Politics, Pixels and Power
The White House has turned political messaging into an arcade game, and the result is less funny that it seems. On Sept. 3, a collection of five retro-style games designed around President Donald Trump’s policies were launched on the White House’s website. The games take familiar arcade throwbacks and give them a MAGA makeover, turning...
Lee Health: The opportunities you don’t see coming
People often ask me, especially now as my tenure as Lee Health’s president and CEO comes to a close at the end of September.
Dartmouth Health Children’s hospital receives $30M gift, new name
A $30 million dollar gift to Dartmouth Health Children’s hospital from entrepreneur Tom Golisano is giving the facility an upgrade and a new name.
Dartmouth Health Children’s hospital receives $30 million gift and a new name
A $30 million dollar gift to Dartmouth Health Children’s hospital from entrepreneur Tom Golisano is giving the facility an upgrade and a new name.
Iconic Spurs entertainment tradition returns
Spurs fans will notice an electrifying new addition to the game day experience at Frost Bank Center this season. After eight long years, the iconic all-female dance group — the Silver Dancers — will grace the sidelines once again. Spurs Sports and Entertainment originally dismantled the team in 2018 after their 26th season due to...
AZ's R&D chief Barr touts internal 'science success story' after IL-33 antibody's stellar showing in COPD
With a detailed data drop that AstraZeneca’s R&D chief described as an internal “science success story,” the British Big Pharma has secured an FDA priority review for what it believes could become a flagship biologic in chronic obstructive pulmonary disease (COPD). In detailed results from the late-stage Oberon and Titania trials—first teased in March and detailed in full at the European Respiratory Society Congress in Barcelona this week—the drugmaker laid out the extent of its IL-33 inhibitor’s potential to reduce moderate and severe exacerbations in a wide range of COPD patients still struggling with those “lung attacks,” as AstraZeneca’s Sharon Barr, Ph.D., called them, despite using standard-care inhaled therapy. In the headline results, a 300 mg dose of tozorakimab given once every four weeks curbed those moderate and severe exacerbations in the studies’ primary population of former smokers by 29% in the Oberon study and 34% in Titania. In the overall population of both current and former smokers, these reductions were 30% and 29%, respectively, versus placebo and inhaled standard of care. The benefits also extended to clinically meaningful exacerbation reductions in all prespecified patient subgroups and specifically turned up promising signals in patients across a range of blood eosinophil counts, with Barr telling Fierce that “it’s the details that make this even more exciting than the high-level results that we’ve already shared.” In fact, during AZ’s tozorakimab poster presentation at the ERS 2026 Congress this past weekend, attendees were so enamored by the data that event organizers had to encourage people to clear the room and look at the other presentations on offer, Barr said in an interview. “I think it really speaks to the fact that there is a lot of buzz around these data because the entire respiratory community has been so desperate for new therapies for these patients,” she explained. The respiratory disease continues to represent a “staggering unmet medical need,” Barr said, highlighting the COPD exacerbations that the Oberon and Titania studies homed in on, which she added carry a greater mortality risk than a heart attack. “When a patient has a severe exacerbation, only about half of them are still alive within three and a half years,” she pointed out. As for tozorakimab specifically, Barr christened the molecule “an AstraZeneca science success story,” harkening several years back to the point at which researchers began to explore IL-33 as a driver of respiratory disease, and COPD in particular. At the same time, “there was still so much that wasn’t understood,” she admitted, highlighting the insight that IL-33 signals through both ST2 and EGFR through the RAGE pathway, a discovery Barr attributed to AstraZeneca's own scientists. Understanding the need to tackle both pathways in COPD—and aware of competitor candidates in the hopper, including one that bound ST2—the company ultimately had to make some “courageous decisions,” Barr said. These included taking a prior COPD molecule offline and going back to the drawing board to reinvent its potential IL-33 label “to make sure that we had a molecule that could block signaling through both arms of the pathway, through both the reduced form and the oxidized form, knowing that we wouldn’t be first, but striving to be best.” “When we put [tozorakimab] into the clinic, we firmly believed that we had a differentiated molecule, and we saw the other molecules blocking just ST2 or partially blocking IL-33, unable to deliver two positive pivotal studies in COPD,” Barr explained. “We kept marching forward because we believed our molecule was differentiated, and now I think we have the clinical validation that supports that.” Ultimately, AstraZeneca finds itself on much better footing these days when it comes to potential biologic rivals to tozorakimab in COPD. Sanofi and Regeneron’s Dupixent, for instance, is approved to treat COPD exacerbations in patients with high eosinophil counts, but not low ones. Meanwhile, the future has become cloudier for other next-gen IL-33 candidates from Sanofi and Regeneron, as well as Roche, which have suffered trial flops in recent years. One other potential ingredient for AstraZeneca’s success in its duo of studies was that the company was “ambitious in the trial design, willing to look at an all-comers population,” Barr said, “and willing to enroll the most severe patients.” Prior studies for would-be biologics rivals in COPD “avoided enrolling” those patients, she pointed out. She also highlighted the Big Pharma’s painstaking design of exacerbations in its trial, which “gave us a very rigorous readout,” and pointed to “the extra effort and investment” the company put in to understand the effect of mucus plugs in patients. Barr described mucus production as a “key feature in disease diversity,” noting that mucus plugs—obstructing clumps of mucus that block patients’ airways—are associated with worse outcomes in COPD. In its data announcement, AstraZeneca noted that an integrated analysis of Oberon and Titania found tozorakimab “demonstrated a reduction in patients’ mucus plug score,” with the pharma claiming its biologic is the first to deliver such results in a broad COPD population. “So being able to reduce those mucus plugs, we expect, is an important part of driving benefit for patients who are living with COPD,” Barr said. Again touching on the breadth of the study populations, Barr added that tozorakimab “worked across all eosinophil levels in both current and former smokers across all levels of lung function,” which she suggested “really simplifies decision-making for clinicians, and it allows them to offer therapy to the broadest possible patient population.” In the highest patient eosinophil count group, tozorakimab helped chart a 43% reduction in exacerbation risk, which Barr stressed were “unprecedented data.” In the mid-level group, AZ’s drug delivered a 23% reduction and, in the lowest group, a 34% reduction in eosinophils, which Barr said suggests efficacy “in all patient subgroups.” As for AZ’s recent guidance upgrade on the medicine’s sales opportunity, the lift from a $3 billion to $5 billion range to $5 billion plus was informed by multiple factors, Barr said, including the fact that “in 2024, there were multiple competitors, and there aren’t anymore.” Additionally, “we know that this is a massive unmet medical need, and this is a really incredible set of data that we think will be very convincing to the clinical community,” Barr said. Looking ahead to a potential evolution of the COPD treatment landscape, Barr noted that most patients start treatment in the community with an option like a triple therapy, and for them, having an option like AstraZeneca’s inhaler Breztri will remain a “really important part” of that journey. But of the patients uncontrolled on triple therapy, which Barr described as “about half of them today,” just a “small fraction” are currently eligible for biologic therapy, which she emphasized AstraZeneca is working to change. Understanding that COPD is not a “one-size-fits-all” disease, AstraZeneca is also looking at its antibody drug Tezspire for patients with T2-driven disease, and the company continues to think about new mechanisms for tackling COPD through both systemic and inhaled drugs, Barr said.
Is Nunes out of favour?
The role of Matheus Nunes in Enzo Maresca's team has been the subject of several questions sent in via our Manchester City Ask me Anything form. Nunes has not featured much this season because he has sustained a couple of knocks in recent weeks - and that has led to Abdukodir Khusanov being deployed at right-back. The Portugal international limped out of the Community Shield defeat by Arsenal just minutes before kick-off and played half an hour in the opening Premier League win over Bournemouth.
Mainz roll 5-0 over hapless SV Hamburg
Phililip Tietz scored a brace and Sheraldo Becker added a goal and two assists as Mainz claimed an impressive 5-0 Bundesliga victory at out-of-sorts SV Hamburg on Sunday. Beaten 4-0 in Hamburg last season, Mainz were determined to make amends from the kick-off and took a 19th-minute lead from Becker's solo after Kaishu Sano intercepted a terrible pass from Hamburg's Nicolai Remberg.
Luis Campusano delivers walk-off win for Padres
News to know about your San Diego Padres and MLB for September 5, 2026.
Pol Espargaró To Continue Subbing For Viñales At Misano
Pol Espargaró will step back onto the Red Bull KTM Tech3 machine for the Grand Prix of San Marino, as Maverick Viñales will sit out a third straight round due to a shoulder injury.
Penn State Health Golisano Children’s Hospital names surgeon-in-chief
Penn State Health Golisano Children’s Hospital has appointed Robert Ricca as surgeon-in-chief, effective Sept. 1.
Sanoja, Gusto help Marlins beat Red Sox 4-0 to avoid series sweep
Javier Sanoja had three hits and drove in a run, Ryan Gusto limited Boston to four hits in 5 2/3 innings and the Miami Marlins beat the Red Sox 4-0 on Wednesday night.
Penn State Health notifies public of potential measles exposure at Penn State Health Golisano Children’s Hospital
Penn State Health is notifying the public of a potential measles exposure at Penn State Health Golisano Children’s Hospital.
COPD: Prioritizing Lung Health in Aging
Don't overlook your lungs. As we age, the risk of COPD increases. Learn the signs and why lung health must be part of the healthy aging conversation.
It’s time to measure what matters in higher education
Commentary: Dr. Ian Mortimer of Golisano Institute highlights the importance of measuring graduate employment and financial independence immediately after college in Rochester.
Bill Clinton visits Rochester to give commencement speech at Golisano Business Institute
The former president told the graduating class that "life's like any other game played.”
What Makes a Fact, According to a Harvard Social Scientist
Sheila Jasanoff has spent her career studying how societies produce knowledge, evaluate expertise, and make decisions about technology.
New Golisano Children’s Mobile Health Clinic to Serve Communities Throughout Rochester
University of Rochester Medicine Golisano Children's launched its Pediatric Mobile Clinic Initiative with a ribbon-cutting ceremony attended by community leaders, healthcare providers, donors, and Rochester leaders.
Sanofi suspends chronic lung disease phase 2 study, tied to ‘strategic business reasons’
Sanofi halted a phase 2 trial testing a monoclonal antibody, SAR445399, in non-cystic fibrosis bronchiectasis, Fierce Biotech has learned. The trial, which began only back in April, was a randomized, double-blind, placebo-controlled study to measure the reduction in mucus plug score following treatment with SAR445399 compared with placebo in adults aged 18 to 80 years with NCFB, a chronic lung disease. The trial was officially reported as halted on July 29, the day before Sanofi’s second-quarter earnings call. The decision to pause the trial was made “as part of a company-wide portfolio review for strategic business reasons,” and not due to safety concerns, a Sanofi spokesperson told Fierce. The move to pause the NCFB trial comes during a trying time for Sanofi following a year filled with a series of trial fails. In February, the French pharma ousted CEO Paul Hudson and appointed Merck KGaA leader Belén Garijo, M.D., Ph.D., to steer the ship. Since then, Garijo has been doing a deep dive on correcting the company’s strewn R&D and clinical strategies. On July 24, Sanofi scrapped amlitelimab for atopic dermatitis, despite its lore as being a potential $5 billion blockbuster. During its second-quarter report, the company abandoned two more assets, balinatunfib and itepekimab, following failed trial results in psoriasis and chronic obstructive pulmonary disease, respectively. SAR445399, only first revealed by Sanofi in 2023, is an anti-interleukin-1 receptor 3 monoclonal antibody developed to block the interleukin 1, 33, and 36 cytokine pathways. These pathways can be important in chronic immune-related dermatologic diseases, such as atopic dermatitis and hidradenitis suppurativa, as well as respiratory conditions, such as NCFB. Related Sanofi’s new CEO ‘looking deeply’ at late-stage pipeline as clinical clearout continues NCFB affects roughly half a million people in the U.S., with a global incidence of greater than one million cases. In August 2025, Insmed received FDA approval for Brinsupri, a DPP1 inhibitor targeting neutrophil activation, for treatment of NCFB in adults and kids ages 12 and older. The British biotech Infex Therapeutics showed promising NCFB phase 2a data using their monoclonal antibody, INFEX702, which acts by disabling Pseudomonas aeruginosa, a bacteria known to be a major pathogen of NCFB. Sanofi is currently running a separate phase 2 study testing SAR445399 as a potential treatment for the inflammatory skin condition hidradenitis suppurativa.
£35m midfielder desperately wanted for deal
Liverpool could be facing a midfielder summer transfer shakeup. There has been no shortage of top performers linked with an inward move to Anfield. Alex Scott and Kaishu Sano are the two latest names ...
Penn State Health celebrates naming of Golisano Children’s Hospital
Penn State Health unveiled new Golisano Children’s Hospital signage on July 24, marking the next chapter in celebrating philanthropist Tom Golisano’s transformational $50 million gift…
Man City's Khusanov signs new five-year contract
Manchester City defender Abdukodir Khusanov signed a five-year contract extension with the Premier League club on Saturday.Khusanov helped City win the FA Cup and League Cup last season, as well as finishing second in the Premier League.
Man City explain Abdukodir Khusanov’s bumper new five-year contract
The Uzbekistan defender is slated for a key role in the new City regime under Enzo Maresca
Khusanov pens new City contract
Abdukodir Khusanov has signed a new five-year contract with Manchester City, keeping him at the Club until 2031.The Uzbek international defender arrived in January 2025 and has enjoyed a stellar first...
Jacqueline Travisano named as one of Triad Business Journal’s 2026 C-Suite Award winners
Executive Vice President and Chief Financial Officer Jackie Travisano was recently named to the Triad Business Journal’s 2026 C-Suite Award winners. Presented annually, the Triad Business Journal’s C-Suite Awards recognize outstanding chief executives and C-level leaders in the Greater Greensboro and Winston-Salem regions who [...]
D-backs @ Padres Discussion
Today’s Lineups DIAMONDBACKS PADRES Ketel Marte – 2B Fernando Tatis – RF Ildemaro Vargas – SS Jackson Merrill – CF Corbin Carroll – RF Xander Bogaerts – SS Gabriel Moreno – C Gavin Sheets – 1B Max Kepler – LF Jake Cronenworth – 2B Lourdes Gurriel – DH Luis Campusano – C Nolan Arenado – […]
Flexjet buys Steve Varsano’s The Jet Business | Corporate Jet Investor
TikTok’s favourite business jet broker has been bought by Flexjet. Steve Varsano, founder of The Jet Business will become president.
Entrepreneurs and small business owners: The importance of furthering your education
Commentary: When people think about entrepreneurship, they often picture someone diving in headfirst, learning through trial and error, and figuring things out along the way.
Flexjet Acquires The Jet Business, Names Varsano President
The Jet Business will steer Flexjet fleet additions, subtractions
EXCLUSIVE: Flexjet buys Steve Varsano’s The Jet Business | Corporate Jet Investor
TikTok’s favourite business jet broker has been bought by Flexjet. Steve Varsano, founder of The Jet Business will become president of Flexjet.
Penn State Health Golisano Children’s Hospital named to Newsweek’s “America’s Best Children’s Hospitals 2026” list
Penn State Health Golisano Children’s Hospital has been recognized as one of America’s Best Children’s Hospitals 2026 by Newsweek and Statista. This prestigious ranking evaluates the top 50 children’s…
42nd Children’s Miracle Network Telethon raises $321,497
The 42nd annual Children’s Miracle Network Hershey (CMN) Telethon raised $321,497 to benefit equipment, programs and research at Penn State Health Golisano Children’s Hospital. The event aired June 1…
Children's Miracle Network Telethon | Healthy Champions expands its focus
WGAL visited Penn State Health Golisano Children’s Hospital in Hershey to discuss how the Children’s Miracle Network helps fund programs that keep kids, and even adults, healthy.
Monterey nonprofits and Montage Health provide $110,000 for Casanova fire survivors
Local organizations are teaming up to offer $110,000 in funding to help residents displaced by the Casanova apartment fire in Monterey with housing and recovery support.
The Adventures of Elliot’s development team has quietly been mastering the modern minigame, and its latest action-RPG once again shows us how it’s done
Coming from Square Enix's Team Asano, The Adventures of Elliot: The Millennium Tales carries on a trend we saw in Bravely Default, Octopath Traveler, and beyond
Eduardo Dominguez of VML Health on ‘Chasing the Miracles of Science’ for Sanofi
Eduardo is a global creative director with VML Health. His work includes the groundbreaking “Dogs Without Borders,” in which trained dogs detect cancer through scent, offering early diagnosis in remote regions such as the Amazon, the Sahara,and Los Pueblos Negros. Beyond his creative work, Eduardo regularly writes for medical sector magazines, sharing insights on enhancing Eduardo is a global creative director with VML Health. Over the course of his 10+ year career, he has worked with some of the industry's top talent, delivering projects that have helped improve the lives of thousands.His work includes the groundbreaking “Dogs Without Borders,” trained dogs to detect cancer through scent, offering early diagnosis in remote regions such as the Amazon, the Sahara, and Los Pueblos Negros.
Daily 5 report for May 8: Why this dealer sold his collision repair business
John Masano sold his collision repair business to Driving Force Collision in 2024 to focus on dealership sales and service operations instead.
More political interference at the FDA?
A political appointee gets in the way of a Sanofi drug's approval, and more from STAT's D.C. Diagnosis newsletter.
Punk Politics/Camp Costume is a fashion exhibition curated by (some of my) brilliant Parsons students!
I have the most amazing students. I teach Fashion Journalism at Parsons, as part of its MA Fashion Studies degree, though I have students of all different disciplines throughout the New School in my class — from fine-art photographers to investigative journalists to textile designers. And I learn about all sorts of fascinating things from them, like that designers are adding faux sweat stains to their garments now (part of a trend piece about “anatomy core”) and that real “French girl style” is actually about being “cunti cunta” (aka loud, rude, too much, liberated). So when I found out that some of my students were curating a fashion exhibition opening tonight(!!!), I just knew that it would be brilliant too. Wearable Art is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe It’s called Punk Politics/Camp Costuming1, and it’s up through May 10 at La Sudestada, the wonderful gallery and concept store in Greenpoint, Brooklyn. I asked the exhibit’s lead curator, Ella Birney (a talented costume and knitwear designer from Belfast who also happens to be in my class), all about it. This conversation has been edited for length and clarity. Tell me about the idea of this exhibition and how it came about. Ella Birney: For our Fashion Curation class, we had to pitch [exhibition] proposals to our professor, Jessica [Glasscock], and I really wanted to continue on the themes that I was exploring in my BA when I was studying in London a couple of years ago. My BA was very punk-inspired and very political. Everything I do, as you know from my writing, always has a slight Irish, political twist to it2. So in my BA project, it was looking at knitwear as a conveyor for exploring political identity in somewhere like Ireland, where identity is such a point of contention. And looking at the images that I generated from that project, there was something so camp about the whole thing. Like, it’s so playful and in bad taste to do a political message — like a knitted Union Jack — out of mohair. There’s something very camp about that. So that’s where it kind of became punk politics/camp costuming — looking at how from the 1970s to now there’s been protest through costume and clothing. What was your BA in? It was fashion textiles, knitwear. Very craft heavy, which — craft is never taken seriously either. That’s also a kind of spin [on the punk/camp thing]. The Union Jack knit that you made is included in the show — what is camp about knitting a Union Jack out of mohair? The whole ethos of camp is kind of bad taste, doing things that are tongue in cheek and a bit wink, wink, nudge, nudge. Like, this is a bit silly. Everything I do is like, this is a bit silly. Like, being from the North of Ireland, everything you do is political. So it’s like, everything is going to be looked at in a certain lens anyway, so we may as well lean into it. So the Union Jack was because I come from a mixed marriage — Protestant-Catholic. And in the North of Ireland, that’s still a big deal. And even though I’m a Catholic and brought up in a very like Catholic Nationalist family, there [were] Union Jacks [the symbol of the United Kingdom] on my street. So I was like, then I’m gonna make your Union Jack out of knitwear. And then that kind of all linked back to the punk movement that Vivian Westwood forefronted in the late 70s, [with her stores] Let It Rock and Seditionaries. How did you source your items? Once we decided on this exhibition idea, everyone in the class was put to [think about] what do you think can fit into punk politics/camp costuming and finding designers that fit that brief. Me and my co-curators, Dulcinea Flores and Allison Gramando, made a brief to send out — with a mood board and color stories, stuff like that — and then everyone kind of got to work emailing people. We reached out to other Parsons grads. Even through Instagram stories we’ve been able to reach so many people who were like, Yeah, of course, I’ll write something for this, or Please — let me submit stuff. It actually was quite easy sourcing things. … The Parsons thing gets you quite far. What were some great pieces you got? There’s a Brooklyn-based, nonbinary artist called Buzz Slutsky. I can’t even remember how I found them, but I came across this crazy, shoe thing — they had made all these different shoes out of papier-mâché, and the story behind them is so fantastic, so interesting. They were just so obliging, like, Of course, you can have these for a few weeks. I was really happy about that. And then we have art from a collective here called Art Comes First. And they lent loads of really amazing pieces that just tied everything together. You have your Union Jack knit in the show too. Any other pieces that you made? There’s three of my BA mohair knits. There’s the Union Jack. There’s a mohair with the word “No” — which is based on an old political campaign in Ireland that was “Ulster says no to sodomy.” And then there’s another one that is red, white and blue, like the Union Jack, but has the word “Catholic” on it and lots of holy medals. I’m so happy I got to include those. How many pieces are in the show? Between 49 and 52, something like that. A load of clothing and accessories, shoes. There’s a Brooklyn-based Irish photographer who’s given us photos. There’s also a shopping cart that is an art piece by Art Comes First that has gold knuckle dusters as the handles. There’s also lots of T-shirts, original pins from the 70s and 80s that were from people’s dads. I also brought my record player, and all of [co-curator] Allison’s dad’s original albums so everyone could play records. Oh my gosh! Yeah, it’s cool. Anything else you would like to add? If we get to do an exhibition, why would we not make it political in this day and age? I hope that people come. There’s a lot of history, because it starts back in the 70s. It’s not like chronological or anything, but there are historical objects. I hope people come out of it thinking, out of all the really horrendous decades of the 70s and 80s and 90s, all these amazing subcultures happened. There are horrible political times, but there’s art that comes out of it that lasts. Punk Politics/Camp Costume is on view May 1-10 at La Sudestada, 67 West St. Suite 513, Greenpoint, Brooklyn. RSVP for the opening Friday May 1 6pm-8pm here. There’s also a button-making and patch-making workshop and artist talk May 9. Follow the show’s Instagram page @punkxcamp.parsons. Special shout out to all the students who put on this show: Ella Birney (lead curator), Dulcinea Flores (curator), Allison Gramando (curator), Pierre Sanon (lead exhibition designer), Eliana Daneshvari (exhibition designer), Reilly Lowell (editor), Jess Gayo (researcher/writer), Joyce Gayo (researcher/writer), Maria Magdalena Ugarte Montero (researcher/writer), Cassidy Colarik (exhibition press officer), Shelby Shovein (educator), Sarah Mahnke-Baum (educator), Trinidy Coleman (graphic designer), and Leonie Soravia (project manager). Jessica Glasscock was the faculty advisor. 1 The website is definitely worth checking out. 2 This is true!
Avera receives $35M gift for New Golisano Children’s Hospital
Avera Health receives $35 million gift from philanthropist B. Thomas Golisano, thus renaming its new Sioux Falls women's health and children’s hospital tower the Avera Golisano Children’s Hospital.
Golisano Institute prepares to build business innovation in Buffalo
BUFFALO, N.Y. (WIVB) — In 1971, Tom Golisano had $3,000 and an idea — to start his company Paychex. Decades later, the billionaire from Rochester is inspiring others to find their passi…
AI Giant Anthropic Leans Into Life Sciences With $400M Coefficient Bio Catch
Anthropic in October last year iterated its Claude AI model to better cater to biopharma purposes. Sanofi, Novo Nordisk, AbbVie and others already use Claude in their operations.
How Abdukodir Khusanov Became Man City's New Fan Favorite
Hours after Manchester City's Carabao Cup final win over Arsenal, fans began to praise "absolute beast" Abdukodir Khusanov as a new fan favorite.
Breathing easy: prioritising respiratory health for older adults in Asia Pacific
Highlights the growing burden of respiratory disease in ageing societies and calls for greater attention, outlining actions for earlier prevention, diagnosis and care in Asia Pacific.
First responders light up the night for young patients at Penn State Health Golisano Children’s Hospital
More than 100 emergency vehicles lit up the campus of Penn State Health Golisano Children’s Hospital on Tuesday evening, creating a colorful display during the fifth annual Light Up the Night…
Penn State Health Golisano Children's Hospital hosting fifth annual Light Up the Night event
Around 100 vehicles from more than 65 organizations are filling the night with flashing lights to brighten the spirits of patients and families.
New NAACP, Sanofi Report Unveils Roadmap for Advancing Health Equity Across the Country
The NAACP, in collaboration with Sanofi, released the findings of the ACE Your Health Community Wellness Survey, one of the largest contemporary grassroots assessments of community health resources in the United States. The report, with nearly 23,000 respondents across 47 states, Washington, D.C., and Puerto Rico, provides insights into the real-world conditions that drive health outcomes, from the quality of housing and access to transportation to the pervasive impact of chronic stress.
Media Buying Briefing: Dentsu’s new CEO on how he’s going to grow the business again
Takeshi Sano takes over as global CEO, and brings with him a more outgoing and worldly approach to running the Japanese-owned holding company.
Can our pets really say ‘I love you’? Science is finding out
Pet soundboards are allowing our four-legged friends to press buttons and express themselves in human language. But is it real? UC San Diego professor Federico Rossano shares his research into this social media phenomenon.
‘Behind the Blue’: Lindsay Ragsdale on growing pediatric health care and supporting Project ADAM
In this episode of “Behind the Blue,” Lindsay Ragsdale, chief medical officer of Golisano Children’s at UK, discusses her career at the university, the role of palliative care, the growth of the children’s hospital and her own son’s experience as a pediatric cardiology patient. As a “Woman of Impact” nominee for the American Heart Association’s current fundraising campaign, she also highlights how AHA helps fund an important initiative overseen by a Golisano team — Project ADAM in Kentucky.
More young people are getting dangerously hooked on online sports betting
Online sports betting is quickly growing in popularity. It's a huge boon for state revenue, but it's also resulted in more young people struggling with gambling.
Sanofi to Buy Dynavax to Boost Vaccines Business
Sanofi to Buy Dynavax to Boost Vaccines Business
Students Compete In Science Poster Contest
NEWPORT CITY- Congratulations are in order for Jase Pion (Lowell), Jaxx Corsano (Newport City) and Alex Bathalon (Troy) for their winning posters at the annual North Country Science and Engineering
Children’s Miracle Network reaches historic fundraising milestone
Children’s Miracle Network (CMN) has reached a historic milestone, surpassing $100 million raised to support lifesaving care at Golisano Children’s Hospital at Penn State Health Milton S.